Craft

Sol-Gel Technologies

Stock Price

$0.6

2024-10-29

Market Capitalization

$18 M

2024-10-29

Revenue

$19.4 M

FY, 2025

Sol-Gel Technologies Summary

Company Summary

Overview
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. The Company designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
Type
Public
Status
Active
Founded
1997
HQ
Ness Ziona, IL | view all locations
Website
http://www.sol-gel.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Moshe Arkin, Chairman

    • Gilad Mamlok
    • Ofer Toledano

      Ofer Toledano, VP Research and Development

    • Ofra Levy-Hacham

      Ofra Levy-Hacham, VP Clinical and Regulatory Affairs

      LocationsView all

      1 location detected

      • Ness Ziona, Center District HQ

        Israel

        7 Golda Me'ir St

      Sol-Gel Technologies Financials

      Summary Financials

      Revenue (Q1, 2026)
      $108.0K
      Gross profit (Q1, 2026)
      $108.0K
      Net income (Q1, 2026)
      ($3.7M)
      Cash (Q1, 2026)
      $10.1M
      EBIT (Q1, 2026)
      ($3.9M)

      Footer menu